- Home
- IMNN vs IINN Comparison
IMNN vs IINN Comparison
Compare IMNN & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- IINN
- Stock Information
- Founded
- IMNN 1982
- IINN 2018
- Country
- IMNN United States
- IINN Israel
- Employees
- IMNN N/A
- IINN N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- IINN Medical/Dental Instruments
- Sector
- IMNN Health Care
- IINN Health Care
- Exchange
- IMNN Nasdaq
- IINN Nasdaq
- Market Cap
- IMNN 12.1M
- IINN 13.7M
- IPO Year
- IMNN 1985
- IINN 2021
- Fundamental
- Price
- IMNN $0.77
- IINN $0.85
- Analyst Decision
- IMNN Buy
- IINN Strong Buy
- Analyst Count
- IMNN 2
- IINN 1
- Target Price
- IMNN $14.00
- IINN $2.00
- AVG Volume (30 Days)
- IMNN 5.4M
- IINN 422.8K
- Earning Date
- IMNN 08-13-2025
- IINN 08-14-2025
- Dividend Yield
- IMNN N/A
- IINN N/A
- EPS Growth
- IMNN N/A
- IINN N/A
- EPS
- IMNN N/A
- IINN N/A
- Revenue
- IMNN N/A
- IINN N/A
- Revenue This Year
- IMNN N/A
- IINN N/A
- Revenue Next Year
- IMNN N/A
- IINN N/A
- P/E Ratio
- IMNN N/A
- IINN N/A
- Revenue Growth
- IMNN N/A
- IINN N/A
- 52 Week Low
- IMNN $0.37
- IINN $0.40
- 52 Week High
- IMNN $3.65
- IINN $1.60
- Technical
- Relative Strength Index (RSI)
- IMNN 40.14
- IINN 63.38
- Support Level
- IMNN $0.93
- IINN $0.70
- Resistance Level
- IMNN $1.03
- IINN $0.77
- Average True Range (ATR)
- IMNN 0.18
- IINN 0.06
- MACD
- IMNN -0.10
- IINN 0.01
- Stochastic Oscillator
- IMNN 1.39
- IINN 75.80
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.